Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process

Yu YueCheng; Fan Ye

doi:10.3969/j.issn.1001-5256.2016.09.014

Issue 9

Sep. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(9): 1706-1713

PDF( 1626 KB)

Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process

DOI: 10.3969/j.issn.1001-5256.2016.09.014

Yu YueCheng,
Fan Ye

Liver Disease Center of PLA,Bayi Hospital,Nanjing University of Traditional Chinese Medicine

Received Date: 2016-08-03
Published Date: 2016-09-20

Abstract

Abstract

Up to now,the diagnosis of drug- induced liver injury( DILI) still relies on the exclusive method,and the Roussel Uclaf Causality Assessment Method( RUCAM) is the most commonly used scale. Since the release of the first version of RUCAM scale in 1993,the second version was released in 2015,in which the definition and scoring criteria of each key element were revised appropriately and explained in detail. The Structured Expert Opinion Process( SEOP) was designed by the workgroup of DILI network prospective study,but since it is too complicated and time- and energy- consuming,its application in clinical practice is limited. This article introduces the research and development history and application method of RUCAM,as well as the modifications made in the 2015 version of RUCAM,and briefly compares the difference in bias between RUCAM and SEOP in the diagnosis of DILI. It is pointed out that both RUCAM and SEOP have marked interobserver and intraobserver variabilities,and therefore,it is necessary to explore a more objective,reproducible,accurate,and convenient strategy for the diagnosis of DILI.
- drug-induced liver injury,
- roussel uclaf causality assessment method,
- structured expert opinion process,
- diagnosis

FullText(HTML)

References(10)

References

[1]DANAN G,TESCHKE R.RUCAM in drug and herb induced liver injury:the update[J].Int J Mol Sci,2016,17(1):14-46.

[2]DANAN G,BENICHOU C.Causality assessment of adverse reactions to drugs——I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-1330.

[3]AITHAL GP,WATKINS PB,ANDRADE RJ,et al.Case definition and phenotype standardization in drug-induced liver injury[J].Clin Pharmacol Ther,2011,89(6):806-815.

[4]ROCKEY DC,SEEFF LB,ROCHON J,et al.Causality assessment in drug-induced liver injury using a structured expert opinion process:comparison to the roussel-uclaf causality assessment method[J].Hepatology,2010,51(6):2117-2126.

[5]BEGAUD B,EVREUX JC,JOUGLARD J,et al.Unexpected or toxic drug reaction assessment(imputation).Actualization of the method used in France[J].Therapie,1985,40(2):111-118.

[6]DANAN G.Causality assessment of drug-induced liver injury.Hepatology Working Group[J].J Hepatol,1988,7(1):132-136.

[7]BENICHOU C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11(2):272-276.

[8]HAYASHI PH.Causality assessment in drug-induced liver injury[J].Semin Liver Dis,2009,29(4):348-356.

[9]CHALASANI NP,HAYASHI PH,BONKOVSKY HL,et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol,2014,109(7):950-966.

[10]Drug-induced Liver Disease Study Group,Chinese.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.

Relative Articles

[1]	Jiaxi MA, Tiantian YAO, Hao CHENG, Dan LIU, Yuhan ZHANG, Siyuan DU, Linfei DONG, Linhui HU, Yan WANG, Guiqiang WANG. Value of different assessment scales in the diagnosis of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(6): 1203-1208. doi: 10.12449/JCH240621
[2]	Tingting HE, Qingsheng LIANG, Liping WANG, Longxin LIANG, Xiaohan LI, Yanfei CUI, Jing JING, Zhaofang BAI, Man GONG, Ruilin WANG. Diagnostic values of integrated evidence chain, Roussel Uclaf Causality Assessment Method, and Structured Expert Opinion Process method for drug-induced liver injury[J]. Journal of Clinical Hepatology, 2022, 38(1): 141-147. doi: 10.3969/j.issn.1001-5256.2022.01.022
[3]	Hou JunXing, Yan FenQin, Yu YueCheng. The pathogenesis,diagnosis,and treatment of drug-induced liver injury with extrahepatic adverse drug reactions[J]. Journal of Clinical Hepatology, 2020, 36(3): 497-500. doi: 10.3969/j.issn.1001-5256.2020.03.003
[4]	Jing Jing, He TingTing, Wang RuiLin, Zhang Fan, Niu Ming, Guo YuMing, Zhu Yun, Xiao XiaoHe, Wang JiaBo. Detection of the risk signals of drug-induced liver injury: Challenges and advances[J]. Journal of Clinical Hepatology, 2020, 36(3): 491-496. doi: 10.3969/j.issn.1001-5256.2020.03.002
[5]	Xiao XiaoHe. Combination of medicine and pharmacy assists for precise prevention and control of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 489-490. doi: 10.3969/j.issn.1001-5256.2020.03.001
[6]	Yang Xue, Tu RongFang, Yang JinHui. Research advances in drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 509-513. doi: 10.3969/j.issn.1001-5256.2020.03.006
[7]	Huang Ang, Sun Ying, Zou ZhengSheng. Recent research advances in chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(3): 501-504. doi: 10.3969/j.issn.1001-5256.2020.03.004
[8]	Xing Lu, Wang Yu, Tao YanYan, Liu ChengHai. Clinical evaluation and prognosis prediction of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2019, 35(12): 2820-2823. doi: 10.3969/j.issn.1001-5256.2019.12.039
[9]	Han Ying, Chen Jie, Dan Jing, Liu YanMin, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liu Dan, Huang YunLi, Huang ChunYang, Liao HuiYu. Value of fumarate hydratase antibody in differential diagnosis of autoimmune hepatitis and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2019, 35(6): 1326-1329. doi: 10.3969/j.issn.1001-5256.2019.06.029
[10]	Bian ZhaoLian, Shao JianGuo, Ma Xiong. Differential diagnosis of drug-induced liver injury and autoimmune hepatitis and related therapeutic strategies[J]. Journal of Clinical Hepatology, 2018, 34(6): 1156-1159. doi: 10.3969/j.issn.1001-5256.2018.06.003
[11]	Yu LeCheng, Fan Ye, Chen ChengWei. Diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2018, 34(6): 1160-1165. doi: 10.3969/j.issn.1001-5256.2018.06.004
[12]	Liu ChengHai, Zhu ChunWu. Epidemic features, major causes, and diagnostic evaluation of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(5): 829-832. doi: 10.3969/j.issn.1001-5256.2017.05.007
[13]	Xu CengLi, Gao Min, Guo ChunXia, Xing MinDan, Li Jia. Clinical features of different types of drug-induced liver injury and their association with liver histological changes[J]. Journal of Clinical Hepatology, 2017, 33(5): 924-927. doi: 10.3969/j.issn.1001-5256.2017.05.027
[14]	Chou LiXia, Fan ZuoPeng, Liu Ying, Liang Shan, Nie Wei, Lin Wei, Liu YiRong, Zhang Jing, Hu ZhongJie. Application of a modified diagnostic scale in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(7): 1328-1331. doi: 10.3969/j.issn.1001-5256.2017.07.025
[15]	Ji ChenHua, Zhang ZhuQing, Wang XiaoYuan, Lu ShuMing. Clinical features of elderly patients with drug-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(3): 502-506. doi: 10.3969/j.issn.1001-5256.2017.03.021
[16]	Zhang Dong, Zhang Tao, Wu YuNan, Sun KeWei. A systematic analysis of the application of diagnostic criteria for drug-induced liver injury in China based on the literature[J]. Journal of Clinical Hepatology, 2017, 33(5): 919-923. doi: 10.3969/j.issn.1001-5256.2017.05.026
[17]	Yuan Ling, Yang YongGeng, Shen YouXiu, Ma YingCai. Research advances in drug- induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(2): 375-378. doi: 10.3969/j.issn.1001-5256.2017.02.038
[18]	Fan ZuoPeng, Liang Shan, Nie Wei, Chou LiXia, Chen Jie, Zhang Jing, Jin RongHua, Hu ZhongJie. Application of drug lymphocyte stimulation test using cell counting kit-8 assay in diagnosis of acute drug-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(8): 1562-1565. doi: 10.3969/j.issn.1001-5256.2016.08.026
[19]	Liang Shan, Fan ZuoPeng, Nie Wei, Chou LiXia, Chen Jie, Lin Wei, Liu YiRong, Zhang Jing, Hu ZhongJie. Clinical types and features of chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(12): 2356-2359. doi: 10.3969/j.issn.1001-5256.2016.12.025
[20]	Lu Yi, Yu Hui. Discussion on idiosyncratic drug-induced liver injury in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1215-1217. doi: 10.3969/j.issn.1001-5256.2015.08.008

Supplements(0)

Cited By

Cited by

Periodical cited type(14)

1.	马嘉蹊，姚甜甜，程浩，刘丹，张宇涵，杜思源，董琳菲，胡林慧，王艳，王贵强. 不同评估量表在药物性肝损伤中的诊断价值分析. 临床肝胆病杂志. 2024(06): 1203-1208 . 本站查看
2.	马嘉蹊，程浩，姚甜甜，刘丹，张宇涵，杜思源，董琳菲，胡林慧，王艳，王贵强. 药物性肝损伤评估量表诊断价值研究进展. 肝脏. 2024(06): 748-750+755 .
3.	何婷婷，梁庆升，王丽苹，梁龙鑫，李筱涵，崔延飞，景婧，柏兆方，宫嫚，王睿林. 整合证据链、Roussel Uclaf因果关系评价法、结构化专家观点程序对药物性肝损伤的诊断效用分析. 临床肝胆病杂志. 2022(01): 141-147 . 本站查看
4.	田春秀，郑文灿. 肝损伤合并感染患者抗菌药物临床合理应用的分析. 临床合理用药杂志. 2021(20): 151-152+159 .
5.	罗杠，邢锐君，谷竟，艾莉，吕晓玲，周捷，余露娟. 甲巯咪唑致粒细胞减少及肝损害1例分析. 中国药师. 2020(01): 126-128 .
6.	龙萍，王莉，魏安华. 麝香保心丸联用阿托伐他汀钙治疗急性冠脉综合征致药源性肝损伤病例分析. 医药导报. 2020(07): 1012-1014 .
7.	刘梦，杨玄子，于乐成. 药物性胆汁淤积的发病机制及诊疗现状. 临床肝胆病杂志. 2019(02): 252-257 . 本站查看
8.	孙伟，孙艺文. 药学干预下的依达拉奉致急性肝损伤的监护路径. 中国处方药. 2019(09): 6-7 .
9.	解鑫赫，赵瑞玲. 药物性肝损伤临床诊断的研究进展. 医学综述. 2019(20): 4044-4048+4054 .
10.	孙玉明，张帮杰. 舒肝宁注射液联合还原型谷胱甘肽治疗药物性肝损伤的临床研究. 中西医结合肝病杂志. 2019(06): 516-519 .
11.	王伽伯，张乐，郭玉明，柏兆方，肖小河. 中药药源性肝损伤因果关系的评价策略和方法. 药学学报. 2018(06): 920-928 .
12.	景婧，朱云，宋雪艾，孙永强，王伽伯，肖小河，何婷婷，余思邈，许文涛，王丽苹，王睿林. 中西药物致肝损伤的临床特点与诊断方法研究进展. 中西医结合肝病杂志. 2018(05): 312-315 .
13.	邢敏丹，李嘉，李谦，高敏，文君. 比较药物性肝损伤的不同临床分型方法. 世界华人消化杂志. 2017(33): 2973-2980 .
14.	李兰花，王利丽. 100例药物性肝损伤用药史、危险因素及临床特点探讨. 肝脏. 2017(10): 922-924 .

Other cited types(8)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3292) PDF downloads(512)

Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process

DOI: 10.3969/j.issn.1001-5256.2016.09.014